1 Combined AOPs for Formaldehyde Degradation Using Heterogeneous Nanostructured Catalysts.

2 Combination of Spatial and Frequency Domains for Floating Object Detection on Complex Water Surfaces

4 monoclonal antibody combinations that present synergistic neutralizing activity: a platform for next-generation anti-toxin drugs

5 evaluation of the efficacy and toxicity of protocol cisplatin, 5-fluorouracil, leucovorin compared to protocol fluorouracil, doxorubicin and mitomycin c in locally advanced and metastatic gastric cancer

6 post-operative analgesia after subarachnoid administration of mixture of buprenorphine and lignocaine.

7 anti-convulsant therapy in eclampsia.

8 Combination of active specific immunotherapy or adoptive antibody or lymphocyte immunotherapy with chemotherapy in the treatment of cancer

9 Decontamination of fresh-cut broccoli with a water–assisted UV-C technology and its combination with peroxyacetic acid

10 [Re-treatment guideline of ranibizumab (genetical recombination) in the maintenance phase].

11 Combination of soil organic and inorganic amendments helps plants overcome trace element induced oxidative stress and allows phytostabilisation.

12 Construction of Luminogen Exhibiting Multicolored Emission Switching through Combination of Twisted Conjugation Core and Donor-Acceptor Units.

13 Risk profiles of pork and poultry meat and risk ratings of various pathogen/product combinations.

14 Phase Ib study of the combination of pexidartinib (PLX3397), a CSF-1R inhibitor, and paclitaxel in patients with advanced solid tumors.

15 A Saccharide Chemosensor Array Developed Based on an Indicator Displacement Assay Using a Combination of Commercially Available Reagents.

16 Efficiency enhancement in fluorescent deep-blue OLEDs by boosting singlet exciton generation through triplet fusion and charge recombination rate

17 Combination of adsorption on activated carbon and oxidative photocatalysis on TiO2 for gaseous toluene remediation

18 In vitro activity of a Hos2 deacetylase inhibitor, MGCD290, in combination with echinocandins against echinocandin-resistant Candida species.

19 Pharmacological investigation of 'HIM-CHX': A herbal combination in the experimental muscle wasting condition.

20 Antioxidative effects of supplementing linseed oil-enriched diets with α-tocopherol, ascorbic acid, selenium, or their combination on carcass and meat quality in broilers.

21 Predicting Global Fund grant disbursements for procurement of artemisinin-based combination therapies

22 Accelerated approval and expensive drugs - A challenging combination

23 Biological Characterization and Inhibition of Streptococcus pyogenes ZUH1 Causing Chronic Cystitis by Crocus sativus Methanol Extract, Bee Honey Alone or in Combination with Antibiotics: An In Vitro Study

24 Fused rings with N-oxide and -NH: good combination for high density and low sensitivity energetic materials.

25 Carrier Transport and Recombination Mechanism in Blue Phosphorescent Organic Light-Emitting Diode with Hosts Consisting of Cabazole- and Triazole-Moiety

26 efficacy of chlorhexidine and a riboflavin/UVA combination on fungal agents of keratitis.

27 Effects of Several Common Antifungal Drugs (Clotrimazole, Miconazole, Fluconazole) alone and in Combination with Amphotericin B on Candida Species Isolated from Chronic Candidal Vulvovaginitis

28 Investigating the viability of genetic screening/testing for RA susceptibility using combinations of five confirmed risk loci.

29 Bacillomycin D and its combination with amphotericin B: Promising antifungal compounds with powerful antibiofilm activity and wound-healing potency

30 Efficacy of combinations of colistin with other antimicrobials involves membrane fluidity and efflux machinery

31 Viral dynamics among HCV infected patients with different genotypes treated with genotypic specific or pan-genotypic direct-acting antiviral agent combinations

32 In vitro and in vivo activity of ciprofloxacin/fosfomycin combination therapy against ciprofloxacin-resistant Shigella flexneri isolates

33 Comparison of pegylated interferon monotherapy and de novo pegylated interferon plus tenofovir combination therapy in patients with chronic hepatitis B

34 Entecavir monotherapy versus de novo combination of lamivudine and adefovir for compensated hepatitis B virus-related cirrhosis: a real-world prospective multicenter cohort study

35 In vitro activity of colistin in combination with various antimicrobials against Acinetobacter baumannii species, a report from South Iran

36 In vitro activity and post-antibiotic effects of linezolid in combination with fosfomycin against clinical isolates of Staphylococcus aureus

37 Malaria parasite clearance from patients following artemisinin-based combination therapy in Côte d’Ivoire

38 Carbapenem-resistant Acinetobacter baumannii and Pseudomonas aeruginosa: characterization of carbapenemase genes and E-test evaluation of colistin-based combinations

39 Synergy effect of meropenem-based combinations against Acinetobacter baumannii: a systematic review and meta-analysis

40 Prevalence of multidrug-resistant Gram-negative pathogens isolated from febrile neutropenic cancer patients with bloodstream infections in Egypt and new synergistic antibiotic combinations

41 In vitro antibacterial effect of fosfomycin combination therapy against colistin-resistant Klebsiella pneumoniae

42 In vitro activity of colistin mono- and combination therapy against colistin-resistant Acinetobacter baumannii, mechanism of resistance, and clinical outcomes of patients infected with colistin-resistant A. baumannii at a Thai university hospital

43 A novel combination approach of human polyclonal IVIG and antibiotics against multidrug-resistant Gram-positive bacteria

44 Efficacy of ultraviolet C light at sublethal dose in combination with antistaphylococcal antibiotics to disinfect catheter biofilms of methicillin-susceptible and methicillin-resistant Staphylococcus aureus and Staphylococcus epidermidis in vitro

45 Ceftolozane/tazobactam: a novel antipseudomonal cephalosporin and β-lactamase-inhibitor combination

46 Molecular analysis of markers associated with chloroquine and sulfadoxine/pyrimethamine resistance in Plasmodium falciparum malaria parasites from southeastern Côte-d'Ivoire by the time of Artemisinin-based Combination Therapy adoption in 2005

47 Raltegravir in combination with other antiretroviral agents for the treatment of HIV infection

48 Lercanidipine/enalapril combination in the management of obesity-related hypertension

49 Clinical utility of fixed-dose combinations in hypertension: evidence for the potential of nebivolol/valsartan

50 Current perspectives on combination therapy in the management of hypertension

51 Optimizing combination therapy in the management of hypertension: the role of the aliskiren, amlodipine, and hydrochlorothiazide fixed combination

52 Long-acting nifedipine for hypertensive patients in the Middle East and Morocco: observations on efficacy and tolerability of monotherapy or combination therapy

53 Azilsartan/chlorthalidone combination therapy for blood pressure control

54 Efficacy and tolerability of a single-pill combination of telmisartan 80 mg and hydrochlorothiazide 25 mg according to age, gender, race, hypertension severity, and previous antihypertensive use: planned analyses of a randomized trial

55 Integrated control of hypertension by olmesartan medoxomil and hydrochlorothiazide and rationale for combination

56 Clinical utility of fixed-combination telmisartan–amlodipine in the treatment of hypertension

57 A critical appraisal of the clinical effectiveness of a fixed combination of valsartan, amlodipine, and hydrochlorothiazide in achieving blood pressure goals

58 First-line treatment of hypertension: critical appraisal of potential role of aliskiren and hydrochlorothiazide in a fixed combination

59 Safety and tolerability of fixed antihypertensive combinations in blood pressure control: focus on olmesartan medoxomil and amlodipine combination

60 Critical appraisal of amlodipine and olmesartan medoxomil fixed-dose combination in achieving blood pressure goals

61 Critical appraisal and pooled analysis of telmisartan alone or in combination with hydrochlorothiazide for achieving blood pressure goals

62 Fixed combinations in the pragmatic management of hypertension: focus on aliskiren and hydrochlorothiazide as a single pill

63 Endothelial function, blood pressure control, and risk modification: impact of irbesartan alone or in combination

64 Complementary mechanisms of action and rationale for the fixed combination of perindopril and indapamide in treating hypertension – update on clinical utility

65 Current concepts in combination therapy for the treatment of hypertension: combined calcium channel blockers and RAAS inhibitors

66 Valsartan combination therapy in the management of hypertension – patient perspectives and clinical utility

67 Potential immunotherapeutic role of interleukin-2 and interleukin-12 combination in patients with hepatocellular carcinoma

68 Azilsartan alone and in combination for the treatment of hypertension – clinical utility and patient considerations

69 Efficacy of combinations of colistin with other antimicrobials involves membrane fluidity and efflux machinery

70 Viral dynamics among HCV infected patients with different genotypes treated with genotypic specific or pan-genotypic direct-acting antiviral agent combinations

71 In vitro and in vivo activity of ciprofloxacin/fosfomycin combination therapy against ciprofloxacin-resistant Shigella flexneri isolates

72 Efficacy of combinations of colistin with other antimicrobials involves membrane fluidity and efflux machinery

73 Viral dynamics among HCV infected patients with different genotypes treated with genotypic specific or pan-genotypic direct-acting antiviral agent combinations

74 In vitro and in vivo activity of ciprofloxacin/fosfomycin combination therapy against ciprofloxacin-resistant Shigella flexneri isolates

75 Comparison of pegylated interferon monotherapy and de novo pegylated interferon plus tenofovir combination therapy in patients with chronic hepatitis B

76 Entecavir monotherapy versus de novo combination of lamivudine and adefovir for compensated hepatitis B virus-related cirrhosis: a real-world prospective multicenter cohort study

77 In vitro activity of colistin in combination with various antimicrobials against Acinetobacter baumannii species, a report from South Iran

78 In vitro activity and post-antibiotic effects of linezolid in combination with fosfomycin against clinical isolates of Staphylococcus aureus

79 Malaria parasite clearance from patients following artemisinin-based combination therapy in Côte d’Ivoire

80 Carbapenem-resistant Acinetobacter baumannii and Pseudomonas aeruginosa: characterization of carbapenemase genes and E-test evaluation of colistin-based combinations

81 Synergy effect of meropenem-based combinations against Acinetobacter baumannii: a systematic review and meta-analysis

82 Prevalence of multidrug-resistant Gram-negative pathogens isolated from febrile neutropenic cancer patients with bloodstream infections in Egypt and new synergistic antibiotic combinations

83 In vitro antibacterial effect of fosfomycin combination therapy against colistin-resistant Klebsiella pneumoniae

84 Successful Treatment of Sjögren’s Syndrome Presenting as a Condition Similar to Chronic Capillary Leak Syndrome Using Combination Therapy with High-Dose Intravenous Immunoglobulin and Glucocorticoid

85 Reconstruction for Complex Oromandibular Facial Defects: The Fibula Free Flap and Pectoralis Major Flap Combination

86 In vitro activity of colistin mono- and combination therapy against colistin-resistant Acinetobacter baumannii, mechanism of resistance, and clinical outcomes of patients infected with colistin-resistant A. baumannii at a Thai university hospital

87 A novel combination approach of human polyclonal IVIG and antibiotics against multidrug-resistant Gram-positive bacteria

88 Efficacy of ultraviolet C light at sublethal dose in combination with antistaphylococcal antibiotics to disinfect catheter biofilms of methicillin-susceptible and methicillin-resistant Staphylococcus aureus and Staphylococcus epidermidis in vitro

89 Ceftolozane/tazobactam: a novel antipseudomonal cephalosporin and β-lactamase-inhibitor combination

90 Molecular analysis of markers associated with chloroquine and sulfadoxine/pyrimethamine resistance in Plasmodium falciparum malaria parasites from southeastern Côte-d'Ivoire by the time of Artemisinin-based Combination Therapy adoption in 2005

91 Raltegravir in combination with other antiretroviral agents for the treatment of HIV infection

92 Lercanidipine/enalapril combination in the management of obesity-related hypertension

93 Clinical utility of fixed-dose combinations in hypertension: evidence for the potential of nebivolol/valsartan

94 Current perspectives on combination therapy in the management of hypertension

95 Optimizing combination therapy in the management of hypertension: the role of the aliskiren, amlodipine, and hydrochlorothiazide fixed combination

96 Long-acting nifedipine for hypertensive patients in the Middle East and Morocco: observations on efficacy and tolerability of monotherapy or combination therapy

97 Azilsartan/chlorthalidone combination therapy for blood pressure control

98 Efficacy and tolerability of a single-pill combination of telmisartan 80 mg and hydrochlorothiazide 25 mg according to age, gender, race, hypertension severity, and previous antihypertensive use: planned analyses of a randomized trial

99 Integrated control of hypertension by olmesartan medoxomil and hydrochlorothiazide and rationale for combination

100 Clinical utility of fixed-combination telmisartan–amlodipine in the treatment of hypertension

101 A critical appraisal of the clinical effectiveness of a fixed combination of valsartan, amlodipine, and hydrochlorothiazide in achieving blood pressure goals

Keyword Connections

Journals

Research Groups

Bibliographies